✦ LIBER ✦

Deferasirox: A Review of Its Use for Chronic Iron Overload in Patients with Non-Transfusion-Dependent Thalassaemia

✍ Scribed by Shirley, Matt; Plosker, Greg L.

Book ID: 124089217
Publisher: Springer International Publishing AG
Year: 2014
Tongue: English
Weight: 441 KB
Volume: 74
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-014-0238-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Deferasirox administration for the treat

Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia

✍ Vassilis Ladis; Helen Berdousi; Efstathios Gotsis; Antonis Kattamis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Use of deferiprone for iron chelation in

Use of deferiprone for iron chelation in patients with transfusion-dependent thalassaemia

✍ Saumya Shekhar Jamuar; Angeline Hwei Meeng Lai; Ah Moy Tan; Mei Yoke Chan; Ee Sh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

A pharmaco-economic evaluation of defera

A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan

✍ Ho, Wan-Ling; Chung, Kuo-Piao; Yang, Szu-Sheng; Lu, Meng-Yao; Jou, Shiann-Tarng; 📂 Article 📅 2013 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 204 KB

Effect of iron chelator deferasirox on c

Effect of iron chelator deferasirox on chronic anemia and thrombocytopenia in a transfusion-dependent patient with myelodysplastic syndrome

✍ Takamasa Nishiuchi; Yuichi Okutani; Toshikazu Fujita; Kazuya Yoshida; Hiroaki Oh 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 216 KB

Pharmacokinetics, Metabolism, and Dispos

Pharmacokinetics, Metabolism, and Disposition of Deferasirox in -Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State

✍ Waldmeier, F.; Bruin, G. J.; Glaenzel, U.; Hazell, K.; Sechaud, R.; Warrington, 📂 Article 📅 2010 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 734 KB

A safety, pharmacokinetic and pharmacody

A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade®, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in Japan

✍ Keisuke Miyazawa; Kazuma Ohyashiki; Akio Urabe; Tomoko Hata; Shinji Nakao; Keiya 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 378 KB